<VariationArchive VariationID="2425356" VariationName="NC_000001.10:g.(?_243652296)_(243859038_?)del" VariationType="Deletion" Accession="VCV002425356" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-10" DateCreated="2023-02-13" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1943081" VariationID="2425356">
      <GeneList>
        <Gene Symbol="AKT3" FullName="AKT serine/threonine kinase 3" GeneID="10000" HGNC_ID="HGNC:393" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q43-44</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="243488233" stop="243851079" display_start="243488233" display_stop="243851079" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NT_187519.1" start="500341" stop="867542" display_start="500341" display_stop="867542" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="243651534" stop="244006885" display_start="243651534" display_stop="244006885" Strand="-" />
          </Location>
          <OMIM>611223</OMIM>
          <Haploinsufficiency last_evaluated="2023-05-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=AKT3">Little evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-05-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=AKT3">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="SDCCAG8" FullName="SHH signaling and ciliogenesis regulator SDCCAG8" GeneID="10806" HGNC_ID="HGNC:10671" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q43-44</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="243256041" stop="243500091" display_start="243256041" display_stop="243500091" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NT_187519.1" start="268149" stop="512199" display_start="268149" display_stop="512199" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="243419306" stop="243663392" display_start="243419306" display_stop="243663392" Strand="+" />
          </Location>
          <OMIM>613524</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000001.10:g.(?_243652296)_(243859038_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q43-44</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" innerStart="243652296" innerStop="243859038" display_start="243652296" display_stop="243859038" variantLength="206743" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.(?_243652296)_(243859038_?)del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.(?_243652296)_(243859038_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000001.10:g.(?_243652296)_(243859038_?)del AND Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2" Accession="RCV003116371" Version="4">
        <ClassifiedConditionList TraitSetID="16959">
          <ClassifiedCondition DB="MedGen" ID="C4014738">Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-10-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-10-20" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-13" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22729224</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23745724</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24705253</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="16959" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="21324" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2, SOMATIC</ElementValue>
                <XRef Type="Allelic variant" ID="611223.0003" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2</ElementValue>
                <XRef ID="MONDO:0014407" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MPPH2</ElementValue>
                <XRef Type="MIM" ID="615937" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">MPPH (megalencephaly-postaxial polydactyly-polymicrogyria-hydrocephalus) syndrome is a developmental brain disorder characterized by megalencephaly (brain overgrowth) with the cortical malformation bilateral perisylvian polymicrogyria (BPP). At birth the occipital frontal circumference (OFC) ranges from normal to 6 standard deviations (SD) above the mean for age, sex, and gestational age; in older individuals the range is from 3 to 10 SD above the mean. A variable degree of ventriculomegaly is seen in almost all children with MPPH syndrome; nearly 50% of individuals have frank hydrocephalus. Neurologic problems associated with BPP include oromotor dysfunction (100%), epilepsy (50%), and mild-to-severe intellectual disability (100%). Postaxial hexadactyly occurs in 50% of individuals with MPPH syndrome.</Attribute>
                <XRef ID="NBK396098" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18078" />
                <XRef ID="18078" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27854409</ID>
                <ID Source="BookShelf">NBK396098</ID>
              </Citation>
              <XRef ID="83473" DB="Orphanet" />
              <XRef ID="C4014738" DB="MedGen" />
              <XRef ID="MONDO:0014407" DB="MONDO" />
              <XRef Type="MIM" ID="615937" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7074243" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2023-02-13">
        <ClinVarSubmissionID localKey="NM_005465.4_1_Deletion (exons 2-13)|MedGen:C4014738" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003794814" DateUpdated="2024-06-09" DateCreated="2023-02-13" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22729224</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23745724</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24705253</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the AKT3 protein in which other variant(s) (p.Arg465Trp) have been determined to be pathogenic (PMID: 22729224, 23745724, 24705253). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This variant has not been reported in the literature in individuals affected with AKT3-related conditions. This variant is a gross deletion of the genomic region encompassing exon(s) 2-13 of the AKT3 gene, which includes the termination codon. This deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. While this deletion is not anticipated to lead to nonsense mediated decay, it is expected to alter mRNA translation or result in a truncated protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="AKT3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.(?_243652296)_(243859038_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4014738" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7074243" TraitType="Disease" MappingType="XRef" MappingValue="C4014738" MappingRef="MedGen">
        <MedGen CUI="C4014738" Name="Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

